[ Price : $8.95]
FDA warns Jackson, WI-based Wisconsin Pharmacal about CGMP violations in its production of finished drugs.[ Price : $8.95]
FDA agrees to accept a biosimilar application to compete with Johnson & Johnsons Stelara that does not include clinical efficacy s...[ Price : $8.95]
FDA clears a Medtronic 510(k) for its MiniMed 780G insulin delivery system to integrate with Abbotts Instinct continuous glucose m...[ Price : $8.95]
HHS says FDA is removing members of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) and Childrens Hospita...[ Price : $8.95]
FDA warns Castle Rock, CO-based Compounders International Analytical Laboratory about CGMP violations and deviations in its work t...[ Price : $8.95]
FDA publishes the 2025 OTC drug monograph forecast showing eight items it expects to address over the next three years.[ Price : $8.95]
Johnson & Johnson decides to stop development of nipocalimab in combination with an anti-tumor necrosis factor alpha therapy for r...[ Price : $8.95]
Novocure stops its LUNAR-4 study, a Phase 2 open-label trial testing Tumor Treating Fields together with Mercks Keytruda (pembroli...